We are monitoring the impact of COVID-19 on Vaccine Adjuvant Market Get in touch with us for detailed analysis Know More
Share on

Global Vaccine Adjuvant Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Type, Route of Administration, Mechanism of Action and Region – Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 623
Pages: 175

Vaccine Adjuvant Market Size (2022 to 2027)

As per our research report, the size of the global vaccine adjuvant market is forecasted to grow USD 1072.1 million by 2027, which was worth USD 642 million in 2022. The market is estimated to showcase a CAGR of 10.8% during the forecast period.

The global vaccine adjuvants market comprises veterinary and human adjuvants, which are used to increase the efficiency of vaccines. Vaccine adjuvants are accredited with assisting to boost the immune response in the host post-vaccination. Immunologists and infectious disease specialists are in covenant over the advantageous uses of adjuvants in vaccines today. Notably, as a means to decrease the number of doses, surge the probability of a continuous immunological response and reduce the overall prevalence of the disease.

The immune response to vaccine antigens has been improved with the use of adjuvants for decades. They recover the body's immune reaction and frequently allow for lesser amounts of a deactivated virus or bacteria to be used in a vaccine. However, more than one adjuvant may be present in the final vaccine product.

MARKET DRIVERS 

Increasing incidence of infectious and zoonotic diseases, growing focus on vaccination programs by numerous government bodies, and rising focus on enhanced and long-term immunization besides current and emerging diseases are primarily accelerating the global vaccine adjuvant market.

Additionally, growing R&D expenditure and attainments, associations, and agreements by companies is another major factor driving the growth of this market. Advancements in adjuvant formulations, the growing adoption rate of recombinant subunit, and synthetic vaccines provide an additional boost to the global vaccine adjuvant market. Growth opportunities that are likely to boost the global vaccine adjuvant market are growing demand for vaccine adjuvants, untouched market areas in developing countries are offering sizable shares for adjuvant vaccine manufacturers and key players in the market.

MARKET RESTRAINTS:

Side effects associated with the adjuvants and high toxicity adjuvants are the primary restraint to the global vaccine adjuvant market. High costs associated with adjuvant-based research and established protection is majorly restraining the market growth. The denying effect of adjuvants' toxicity on the vaccine's manufacturing cost and protective profiles inhibit the growing market demand. The adverse effects of adjuvants and high-toxicity adjuvant are factors impeding the vaccine adjuvant market growth during the forecasting timeline. Moreover, insufficient knowledge among people and inadequate healthcare facilities hampers the growing market rate. Low research activities in its development also hinder the market.

Impact of COVID-19 on the global vaccine adjuvant market:

During the pandemic crisis, import and export activities have been restricted because of lockdown. The COVID-19 pandemic crisis is projected to impact market growth positively, majorly. According to a research article in Nature Reviews Immunology 2020, aluminum-based vaccine adjuvants offer a glide path to influence high levels of neutralizing antibodies identified as a basis of the safety allocated by the COVID-19 vaccines. For instance, in May 2020, GSK considered generating 1 billion doses of its pandemic vaccine adjuvant system in 2021 to develop multiple adjuvanted COVID-19, vaccine candidates. India's government (GOI) has permitted INR 100 crores from PM-CARES funds to establish the COVID-19 vaccine. Presently, there are nearly 25 vaccine development work is continuous, in association with industry-academia collaboration. Moreover, in China, in April 2020, announced the surplus funding of USD 30 million to the World Health Organization (WHO) for handling the COVID-19 pandemic. 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

By Type, Route of administration, Mechanism of action, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

 

This market research report on the global vaccine adjuvant market has been segmented based on the type, route of administration, mechanism of action, and region.

Vaccine Adjuvant Market – By Type:

  • Aluminum Salts
  • Tensoactive Adjuvants
  • Adjuvant Emulsions
  • Bacteria Derived Adjuvants
  • Liposome Adjuvants
  • Carbohydrate Adjuvants

Based on type, the carbohydrate adjuvants segment contributes a significant share and is anticipated to grow further during the forecast period.

The aluminum salts type segment is estimated to grow at a healthy CAGR during the forecast period due to rising innovation and the introduction of particulate adjuvants in the market. Aluminum salts vaccine has a presence and growing continuously in the market for the last two decades due to the safety of cancer patients. Also, new adjuvants have come up with an innovative facility such as more muscular battle to disease and having a more shelf life than others due to easier availability of aluminum salts in the nature and high adoption of particulate vaccines.

Vaccine Adjuvant Market – By Route of administration:

  • Oral
  • Intradermal
  • Subcutaneous
  • Intranasal
  • Intramuscular

Based on the administration route, the Intramuscular segment is dominating the vaccine adjuvants market regarding the route of administration as this is the fastest and highly effective route. The intradermal route segment is likely to contribute a significant share to the market as it takes more time for absorption and action. 

Vaccine Adjuvant Market – By Mechanism of Action:

  • Immune Stimulants
  • Carriers
  • Vehicle Adjuvants

Based on the mechanism of action, the Immune Stimulants segment dominates the market due to the high demand for adjuvants for stimulating antigens to the immune system.

Vaccine Adjuvant Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

North America, followed by Europe, lead the vaccine adjuvants market. Growth in the North American segment is mainly driven by the fast-increasing elderly population and rising government funding in North American countries. The North American market is also overgrowing due to innovations and increasing product portfolios of the key players, a rise in investments of R & D.

The European market is dominating due to an increase in patients affected by diseases like cancer and other infections. The Asia Pacific and Africa are displaying consistent growth and expected to maintain the trend due to the increasing population and diseases like HIV, hepatitis, cancer, influenza, and others.

KEY MARKET PARTICIPANTS:

Some of the promising companies operating in the global vaccine adjuvants market include MPV Technologies (U.S.), Avanti Polar Lipids, Novavax Inc. (U.S.), Brenntag Biosector (Denmark), SEPPIC (France), Agenus, Inc. (U.S.), Invivogen (U.S.), SPI Pharma, Inc. (U.S.), CSL Limited (Australia), and OZ Biosciences (France).

RECENT MARKET DEVELOPMENTS:

  • In 2020, The U.S. food and drug administration approved Seqirus for its new product AUNDEZ to treat Influenza prevention. It is the first monovalent vaccine adjuvant to protect against influenza A H5N1 in the pandemic situation.
  • In 2020, GSK announced it comes into the market with innovative doses of vaccine adjuvant to enhance the COVID-19 outbreak. GSK has invested a high amount in developing 1 billion doses of adjuvanted vaccine next year.
  • In 2018, Croda acquired the Brenntag bio sector to develop an adjuvant vaccine for serving humans and the veterinary market.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Aluminium Salts    

                                5.1.2 Tensoactive Adjuvants      

                                5.1.3 Adjuvant Emulsions            

                                5.1.4 Bacteria derived Adjuvants              

                                5.1.5 Liposome Adjuvants           

                                5.1.6 Carbohydrate Adjuvants   

                5.2 By Route of Administration                 

                                5.2.1 Oral            

                                5.2.2 Intradermal            

                                5.2.3 Subcutaneous       

                                5.2.4 Intranasal                

                                5.2.5 Intramuscular        

                5.3 By Mechanism of Action                       

                                5.3.1 Immuno Stimulants             

                                5.3.2 Carriers     

                                5.3.3 Vehicle Adjuvants

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 South Korea           

                                6.3.6 Australia   

                6.4 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Mexico     

                                6.4.4 Argentina

                                6.4.5 Rest of Latin America          

                6.5 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 MPV Technologies                  

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Avanti Polar Lipids                   

                8.3 Novavax Inc.                              

                8.4 Brenntag Biosector                 

                8.5 SEPPIC                          

                8.6 Agenus, Inc.                               

                8.7 Invivogen                    

                8.8 SPI Pharma Inc.                         

                8.9 CSL Limited                 

                8.10 OZ Biosciences                        

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1.  Global Vaccine Adjuvant Market, By Region, From 2022 - 2027 (USD Million)
  2. Global Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  3. Global Aluminium Salts Market, By Region, From 2022 - 2027 (USD Million)
  4. Global Tensoactive Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  5. Global Adjuvant Emulsions Market, By Region, From 2022 - 2027 (USD Million)
  6. Global Bacteria derived Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  7. Global Liposome Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  8. Global Carbohydrate Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  9. Global Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  10. Global Oral Market, By Region, From 2022 - 2027 (USD Million)
  11. Global Intradermal Market, By Region, From 2022 - 2027 (USD Million)
  12. Global Subcutaneous Market, By Region, From 2022 - 2027 (USD Million)
  13. Global Intranasal Market, By Region, From 2022 - 2027 (USD Million)
  14. Global Intramuscular Market, By Region, From 2022 - 2027 (USD Million)
  15. Global Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  16. Global Immuno Stimulants Market, By Region, From 2022 - 2027 (USD Million)
  17. Global Carriers Market, By Region, From 2022 - 2027 (USD Million)
  18. Global Vehicle Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  19. North America Vaccine Adjuvant Market, By Region, From 2022 - 2027 (USD Million)
  20. North America Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  21. North America Aluminium Salts Market, By Region, From 2022 - 2027 (USD Million)
  22. North America Tensoactive Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  23. North America Adjuvant Emulsions Market, By Region, From 2022 - 2027 (USD Million)
  24. North America Bacteria derived Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  25. North America Liposome Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  26. North America Carbohydrate Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  27. North America Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  28. North America Oral Market, By Region, From 2022 - 2027 (USD Million)
  29. North America Intradermal Market, By Region, From 2022 - 2027 (USD Million)
  30. North America Subcutaneous Market, By Region, From 2022 - 2027 (USD Million)
  31. North America Intranasal Market, By Region, From 2022 - 2027 (USD Million)
  32. North America Intramuscular Market, By Region, From 2022 - 2027 (USD Million)
  33. North America Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  34. North America Immuno Stimulants Market, By Region, From 2022 - 2027 (USD Million)
  35. North America Carriers Market, By Region, From 2022 - 2027 (USD Million)
  36. North America Vehicle Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  37. United States Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  38. United States Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  39. United States Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  40. Canada Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  41. Canada Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  42. Canada Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  43. Europe Vaccine Adjuvant Market, By Region, From 2022 - 2027 (USD Million)
  44. Europe Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  45. Europe Aluminium Salts Market, By Region, From 2022 - 2027 (USD Million)
  46. Europe Tensoactive Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  47. Europe Adjuvant Emulsions Market, By Region, From 2022 - 2027 (USD Million)
  48. Europe Bacteria derived Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  49. Europe Liposome Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  50. Europe Carbohydrate Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  51. Europe Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  52. Europe Oral Market, By Region, From 2022 - 2027 (USD Million)
  53. Europe Intradermal Market, By Region, From 2022 - 2027 (USD Million)
  54. Europe Subcutaneous Market, By Region, From 2022 - 2027 (USD Million)
  55. Europe Intranasal Market, By Region, From 2022 - 2027 (USD Million)
  56. Europe Intramuscular Market, By Region, From 2022 - 2027 (USD Million)
  57. Europe Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  58. Europe Immuno Stimulants Market, By Region, From 2022 - 2027 (USD Million)
  59. Europe Carriers Market, By Region, From 2022 - 2027 (USD Million)
  60. Europe Vehicle Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  61. U.K Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  62. U.K Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  63. U.K Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  64. Spain Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  65. Spain Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  66. Spain Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  67. Germany Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  68. Germany Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  69. Germany Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  70. Italy Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  71. Italy Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  72. Italy Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  73. France Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  74. France Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  75. France Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  76. Asia-Pacific Vaccine Adjuvant Market, By Region, From 2022 - 2027 (USD Million)
  77. Asia-Pacific Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  78. Asia-Pacific Aluminium Salts Market, By Region, From 2022 - 2027 (USD Million)
  79. Asia-Pacific Tensoactive Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  80. Asia-Pacific Adjuvant Emulsions Market, By Region, From 2022 - 2027 (USD Million)
  81. Asia-Pacific Bacteria derived Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  82. Asia-Pacific Liposome Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  83. Asia-Pacific Carbohydrate Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  84. Asia-Pacific Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  85. Asia-Pacific Oral Market, By Region, From 2022 - 2027 (USD Million)
  86. Asia-Pacific Intradermal Market, By Region, From 2022 - 2027 (USD Million)
  87. Asia-Pacific Subcutaneous Market, By Region, From 2022 - 2027 (USD Million)
  88. Asia-Pacific Intranasal Market, By Region, From 2022 - 2027 (USD Million)
  89. Asia-Pacific Intramuscular Market, By Region, From 2022 - 2027 (USD Million)
  90. Asia-Pacific Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  91. Asia-Pacific Immuno Stimulants Market, By Region, From 2022 - 2027 (USD Million)
  92. Asia-Pacific Carriers Market, By Region, From 2022 - 2027 (USD Million)
  93. Asia-Pacific Vehicle Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  94. China Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  95. China Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  96. China Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  97. India Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  98. India Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  99. India Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  100. Japan Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  101. Japan Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  102. Japan Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  103. South Korea Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  104. South Korea Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  105. South Korea Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  106. Australia Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  107. Australia Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  108. Australia Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  109. Latin America Vaccine Adjuvant Market, By Region, From 2022 - 2027 (USD Million)
  110. Latin America Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  111. Latin America Aluminium Salts Market, By Region, From 2022 - 2027 (USD Million)
  112. Latin America Tensoactive Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  113. Latin America Adjuvant Emulsions Market, By Region, From 2022 - 2027 (USD Million)
  114. Latin America Bacteria derived Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  115. Latin America Liposome Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  116. Latin America Carbohydrate Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  117. Latin America Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  118. Latin America Oral Market, By Region, From 2022 - 2027 (USD Million)
  119. Latin America Intradermal Market, By Region, From 2022 - 2027 (USD Million)
  120. Latin America Subcutaneous Market, By Region, From 2022 - 2027 (USD Million)
  121. Latin America Intranasal Market, By Region, From 2022 - 2027 (USD Million)
  122. Latin America Intramuscular Market, By Region, From 2022 - 2027 (USD Million)
  123. Latin America Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  124. Latin America Immuno Stimulants Market, By Region, From 2022 - 2027 (USD Million)
  125. Latin America Carriers Market, By Region, From 2022 - 2027 (USD Million)
  126. Latin America Vehicle Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  127. Brazil Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  128. Brazil Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  129. Brazil Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  130. Argentina Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  131. Argentina Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  132. Argentina Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  133. Mexico Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  134. Mexico Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  135. Mexico Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  136. Middle East & Africa Vaccine Adjuvant Market, By Region, From 2022 - 2027 (USD Million)
  137. Middle East & Africa Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  138. Middle East & Africa Aluminium Salts Market, By Region, From 2022 - 2027 (USD Million)
  139. Middle East & Africa Tensoactive Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  140. Middle East & Africa Adjuvant Emulsions Market, By Region, From 2022 - 2027 (USD Million)
  141. Middle East & Africa Bacteria derived Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  142. Middle East & Africa Liposome Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  143. Middle East & Africa Carbohydrate Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  144. Middle East & Africa Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  145. Middle East & Africa Oral Market, By Region, From 2022 - 2027 (USD Million)
  146. Middle East & Africa Intradermal Market, By Region, From 2022 - 2027 (USD Million)
  147. Middle East & Africa Subcutaneous Market, By Region, From 2022 - 2027 (USD Million)
  148. Middle East & Africa Intranasal Market, By Region, From 2022 - 2027 (USD Million)
  149. Middle East & Africa Intramuscular Market, By Region, From 2022 - 2027 (USD Million)
  150. Middle East & Africa Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  151. Middle East & Africa Immuno Stimulants Market, By Region, From 2022 - 2027 (USD Million)
  152. Middle East & Africa Carriers Market, By Region, From 2022 - 2027 (USD Million)
  153. Middle East & Africa Vehicle Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  154. Middle East Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  155. Middle East Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  156. Middle East Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  157. Africa Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  158. Africa Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  159. Africa Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

4255


pdf excel
$

5060


pdf excel powerbi
$

7360


excel
$

2500

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 4255

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample